Table 3.
Studies on ablation therapy for liver metastasis from breast cancer
| Author | Publication year | Type of ablation | No. of patients | No. of tumors | Size of tumors [mm] | Follow-up [months] | Local tumor control [%] | Overall survival [months] | Overall survival [%] | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year | 2-year | 3-year | 4-year | 5-year | |||||||||
| Schullian et al. [29] | 2021 | RFA | 42 | 110 | 30 (median) | 10.9 (median) | 92.7 | 32.3 (median) | 84.1 | – | 49.3 | – | 20.8 |
| Bai et al. [30] | 2019 | RFA | 69 | 135 | 29 (median) | 26 (median) | 88.4 | 26 (median) | 81.8 | 50.1 | 25.3 | – | 11 |
| Bale et al. [31] | 2018 | RFA | 26 | 64 | 28 (median) | 23.1 (median) | 92.2 | 29.3 (median) | – | – | – | – | – |
| Kümler et al. [32] | 2015 | RFA | 32 | – | 20 (median) | – | 78 | 33.5 (median) | 87 | 68 | 48 | – | – |
RFA radiofrequency ablation